Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease - Wikidata - wikimedia - TriplyDB

Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease

Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease

http://www.wikidata.org/entity/Q28235112

about

Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin Laboratory use of hepcidin in renal transplant recipients Immune dysfunction in uremia—an update Peering into the future: hepcidin testing Hepcidin and iron regulation, 10 years later.Mechanisms of anemia in CKD.Evidence for a lack of a direct transcriptional suppression of the iron regulatory peptide hepcidin by hypoxia-inducible factors Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients.Unexplained aspects of anemia of inflammation.Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS.The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease.Serum hepcidin may be a novel uremic toxin, which might be related to erythropoietin resistance Reduction of serum hepcidin by hemodialysis in pediatric and adult patients.Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD.Hepcidin levels in diabetes mellitus and polycystic ovary syndrome.Tubular reabsorption and local production of urine hepcidin-25.Treatment of chronic periodontitis decreases serum prohepcidin levels in patients with chronic kidney disease.Correction of iron deficiency in the cardiorenal syndrome Iron dosing in kidney disease: inconsistency of evidence and clinical practice.A 3-marker index improves the identification of iron disorders in CKD anaemia.Hepcidin and risk of anemia in CKD: a cross-sectional and longitudinal analysis in the CKiD cohort.Does erythropoietin cause hemoglobin variability--is it 'normal'?Hepcidin-25 in diabetic chronic kidney disease is predictive for mortality and progression to end stage renal disease.Inflammation-induced hepcidin-25 is associated with the development of anemia in septic patients: an observational study.Hemodiafiltration improves plasma 25-hepcidin levels: a prospective, randomized, blinded, cross-over study comparing hemodialysis and hemodiafiltration.Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial Serum prohepcidin levels are potential prognostic markers in patients with multiple myeloma Understanding and exploiting hepcidin as an indicator of anemia due to chronic kidney disease.The relationship between anemia, liver disease, and hepcidin levels in hemodialysis patients with hepatitis.Can Serum Gdf-15 be Associated with Functional Iron Deficiency in Hemodialysis Patients?Four-Week Studies of Oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia Plasma hepcidin levels and anemia in old age. The Leiden 85-Plus Study.A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats.Hepcidin-25 negatively predicts left ventricular mass index in chronic kidney disease patients Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.The iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients.Study of anemia in nondialysis dependent chronic kidney disease with special reference to serum hepcidin Iron-refractory iron deficiency anemia: new molecular mechanisms.

P2860

Q24632978-98430D2F-0251-4A0F-B734-A34B4DF9DC3A Q26765316-EBC0B099-788A-4954-88E5-AC13C248A2BE Q26829076-D7C65831-B4E8-497A-ACAA-F502FD6740C5 Q27021098-0BB28C25-B422-4DE5-9D50-40F9DF5017A5 Q27690828-930BD4C9-B1F2-4FB1-A043-7F6D382BFE94 Q27693202-CC88A8E2-A886-4DB4-AE8A-C5358B19632F Q28471913-5673A965-986E-43A7-9E17-B8D3D751CF00 Q28727076-9C1A5E54-AB8E-41D3-B0DB-37198AFDF6E5 Q33559201-E3AE8890-4EDF-4AEF-8C5B-57C546E7CC1E Q33625004-756794A8-36CA-410E-A02B-489EF6C051F5 Q33756604-40E16B24-800B-4280-8BFE-B59B6FA26D47 Q33802213-3DC844DB-3828-4E57-9257-E0878C27B3A9 Q33825492-569111C5-82CA-476E-A441-5904AF09C52D Q33835256-D9722701-8D84-4044-8C04-F1613D5A1256 Q33888363-BFA535B7-F432-4436-8A3D-2836C040C02F Q33999246-440F77FF-1E7F-4CDD-B8E3-3AA437EEB76E Q34516634-8C8810C9-7711-4603-844E-B99CE2A23BB1 Q34636734-5FE2D88E-0253-4F40-A2CB-26650B183444 Q34978781-BF79A33E-59D5-45AB-ADBA-E1FCC22A59E4 Q34989324-1F5C58B6-A10B-48CE-A821-C4CCA4CD5A55 Q35022235-C62E3E6F-7A08-4E77-8993-1679AF712B6A Q35105827-C2FBFACF-F6C3-4B7A-983B-B9484DFD95A8 Q35106901-60D85F78-2F16-4544-AF1A-50BC666F6176 Q35141653-20A9A668-11B8-40A2-842C-09BE071F7197 Q35499717-09E0AE4C-305A-4A96-87E9-D23C882B75C1 Q35567161-445E27A5-E274-4C9F-8E1D-63FD46A55657 Q35953337-E02C3A3B-E294-47A1-ADC7-AB49034C17B2 Q36045015-12DAE02B-D7E0-430C-99F6-62CB9034E68D Q36409102-CDE1F345-A5F1-411E-93CB-FBAFE4DF46DA Q36471843-056994AC-A7AA-46C0-BC9D-778A33B7A4A6 Q36612796-A6EBDFD1-A643-4DB2-B7E5-A18DD2850CAE Q36679596-351E76E7-8043-4AC8-A720-204FC09E0FC6 Q36746039-549EF6F3-A54C-4A4F-AA94-F42992819E02 Q36862324-2E984273-6E60-4C16-ABC4-FDB2276D78D5 Q37000231-749AA3AC-99AB-490B-A655-6B2A56239A73 Q37195436-431296A6-A73B-41B9-9ED6-07F16999B130 Q37211057-63970D41-9B84-4E60-9092-C46871F9E29D Q37542851-B86918F5-B290-43D7-B8C6-0C3DEDD3CA4E Q37599295-4AC40BDD-AA24-432B-A7FD-26D4E3332424 Q37602503-ACD9ED81-81D0-4F7B-B16E-0158AB9866B3

P2860

Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease

http://www.wikidata.org/entity/Q28235112

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Plasma hepcidin levels are ele ...... ietin therapy in renal disease

@ast

Plasma hepcidin levels are ele ...... ietin therapy in renal disease

@en

Plasma hepcidin levels are ele ...... ietin therapy in renal disease

@nl

type

label

Plasma hepcidin levels are ele ...... ietin therapy in renal disease

@ast

Plasma hepcidin levels are ele ...... ietin therapy in renal disease

@en

Plasma hepcidin levels are ele ...... ietin therapy in renal disease

@nl

prefLabel

Plasma hepcidin levels are ele ...... ietin therapy in renal disease

@ast

Plasma hepcidin levels are ele ...... ietin therapy in renal disease

@en

Plasma hepcidin levels are ele ...... ietin therapy in renal disease

@nl

P1433

Q28235112-B2D22C50-45E7-4154-9A02-6E0E6E46B96A

P1476

Q28235112-8A43D23E-D8AF-445B-8C3D-FBE0CCDB7CE2

P2093

Q28235112-0ADFD5A9-1E1B-4E0C-965B-F4C1E6337F74

Q28235112-3009010F-DA5F-42CD-A993-586DD2F3CE22

Q28235112-3F9375F7-E35F-4A63-803D-9B7586AE0CD4

Q28235112-4E9218C9-C9A5-4593-A468-DDA4B0B4CABD

Q28235112-6F08E1A2-E6D1-471A-A29A-9C9680D5F6D5

Q28235112-6FDAA011-1CC2-4889-97C1-5C2A7DDCF0E8

Q28235112-AC31952F-B97F-4BC8-A1A1-D3D7BA335C3E

Q28235112-AE31E3FC-F6F1-45BF-BC83-5662AD49ABF5

P2888

Q28235112-8920977B-69C6-443E-AB70-3F53F7D32CB5

P304

Q28235112-C5705F70-8B6F-454F-8EBE-64FA032F74DA

P31

Q28235112-756CD5AA-3C7C-4A3C-ADD8-A2C89DA41B54

P3181

Q28235112-271B0FC5-9A2A-4DC4-B92A-458396887A20

P356

Q28235112-9EEA4A6D-B9D3-4B51-B0E3-FC95E8148239

P407

Q28235112-90B1FDFF-2567-47A9-83B3-C257B669D131

P433

Q28235112-FD078F84-29D1-4BD4-8793-8EA58579CD06

P478

Q28235112-01E5C8CD-C84E-47F3-A59D-8FD70EA43BB2

P50

Q28235112-40F80DC1-E094-4E95-86BE-EB928689E649

Q28235112-763F79DF-BB7F-4525-8A6E-C2D8526038B8

Q28235112-9FC6DC45-1FEB-4B0E-9E6C-53ECE499C278

Q28235112-A73F2943-9351-4FE9-94E8-468758377843

P577

Q28235112-7FC48090-0402-42E5-AFD9-3322013E3483

P5875

Q28235112-F2E8075F-6974-46EF-84DD-2BB7466E1500

P6179

Q28235112-F33F3A05-A097-4EAB-9810-F1054A153A70

P698

Q28235112-8C8FADC1-CA71-40D2-A97A-2DD892684B6B

P921

Q28235112-ABF5EA8D-3BEA-4993-9546-6ED01B307A43

P3181

P356

P1433

Kidney International

P1476

Plasma hepcidin levels are ele ...... ietin therapy in renal disease

@en

P2093

Damien R Ashby

http://www.w3.org/2001/XMLSchema#string

David H Taube

http://www.w3.org/2001/XMLSchema#string

Frederick W K Tam

http://www.w3.org/2001/XMLSchema#string

Neill D Duncan

http://www.w3.org/2001/XMLSchema#string

Peter Choi

http://www.w3.org/2001/XMLSchema#string

Richard S Chapman

http://www.w3.org/2001/XMLSchema#string

Stephen R Bloom

http://www.w3.org/2001/XMLSchema#string

Tom D Cairns

http://www.w3.org/2001/XMLSchema#string

P2888

P304

976-981

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

938457

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/KI.2009.21

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P50

Patrick H Maxwell

P577

2009-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24003461

http://www.w3.org/2001/XMLSchema#string

P6179

1008730838

http://www.w3.org/2001/XMLSchema#string

P698

19212416

http://www.w3.org/2001/XMLSchema#string

P921